Son Byung Ho, Dominici Laura S, Aydogan Fatih, Shulman Lawrence N, Ahn Sei Hyn, Cho Ja Young, Coopey Suzanne B, Kim Sung Bae, Min H Elise, Valero Monica, Wang Jiping, Caragacianu Diana, Gong Gyung-yub, Hevelone Nathanael D, Baek Seunghee, Golshan Mehra
Department of Breast and Endocrine Surgery, Asan Medical Center, Seoul, Korea E-mail :
Asian Pac J Cancer Prev. 2015;16(6):2531-5. doi: 10.7314/apjcp.2015.16.6.2531.
Breast cancer diagnosed in young women may be more aggressive, with higher rates of local and distant recurrence compared to the disease in older women. Epidemiologic evidence suggests that Korean women have a lower incidence of breast cancer than women in the United States, but that they present at a younger age than their American counterparts. We sought to compare risk factors and management of young women with breast cancer in Boston, Massachusetts (US) with those in Seoul, South Korea (KR).
A retrospective review was performed of consecutive patients less than 35 years old with a diagnosis of breast cancer at academic cancer centers in the US and KR from 2000-2005. Patient data were obtained by chart review. Demographic, tumor and treatment characteristics were compared utilizing Pearson's chi- square or Wilcoxon rank-sum tests where appropriate. All differences were assessed as significant at the 0.05 level.
205 patients from the US and 309 from KR were analyzed. Patients in US were more likely to have hormone receptor positive breast cancer, while patients in KR had a higher rate of triple negative lesions. Patients in US had a higher mean body mass index and more often reported use of birth control pills, while those in the KR were less likely to have a sentinel node procedure performed or to receive post mastectomy radiation.
Patients under 35 diagnosed with breast cancer in the US and KR differ with respect to demographics, tumor characteristics and management. Although rates of breast conservation and mastectomy were similar, US patients were more likely to receive post mastectomy radiation. The lower use of sentinel node biopsy is explained by the later adoption of the technique in KR. Further evaluation is necessary to evaluate recurrence rates and survival in the setting of differing disease subtypes in these patients.
与老年女性的乳腺癌相比,年轻女性被诊断出的乳腺癌可能更具侵袭性,局部和远处复发率更高。流行病学证据表明,韩国女性的乳腺癌发病率低于美国女性,但她们发病的年龄比美国女性更小。我们试图比较美国马萨诸塞州波士顿市和韩国首尔市年轻乳腺癌女性患者的风险因素及治疗情况。
对2000年至2005年在美国和韩国学术癌症中心确诊为乳腺癌的35岁以下连续患者进行回顾性研究。通过查阅病历获取患者数据。在适当情况下,利用Pearson卡方检验或Wilcoxon秩和检验比较人口统计学、肿瘤和治疗特征。所有差异均在0.05水平上被评估为具有显著性。
分析了来自美国的205例患者和来自韩国的309例患者。美国患者更有可能患激素受体阳性乳腺癌,而韩国患者三阴性病变的发生率更高。美国患者的平均体重指数更高,且更常报告使用避孕药,而韩国患者进行前哨淋巴结手术或接受乳房切除术后放疗的可能性较小。
在美国和韩国,35岁以下被诊断为乳腺癌的患者在人口统计学、肿瘤特征和治疗方面存在差异。尽管保乳率和乳房切除率相似,但美国患者更有可能接受乳房切除术后放疗。韩国前哨淋巴结活检使用率较低是由于该技术在韩国采用较晚。有必要进一步评估这些患者不同疾病亚型情况下的复发率和生存率。